Mikko Kuoppamäki
Orion Corporation (Finland)(FI)
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Neurotransmitter Receptor Influence on Behavior, Neuroscience and Neuropharmacology Research, Schizophrenia research and treatment
Most-Cited Works
- → Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients(1995)321 cited
- → Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia(1999)244 cited
- → Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2C receptor(1996)198 cited
- → Clozapine and N-desmethylclozapine are potent 5-HT1C receptor antagonists(1993)125 cited
- → Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP‐treated drug‐naïve primates(2005)112 cited
- → 3,4-Methylenedioxymethamphetamine (Ecstasy) Inhibits Dyskinesia Expression and Normalizes Motor Activity in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Primates(2003)105 cited
- → Striatal presynaptic dopamine function in type 1 alcoholics measured with positron emission tomography(1998)81 cited
- → Comparison of pharmacokinetic profile of levodopa throughout the day between levodopa/carbidopa/entacapone and levodopa/carbidopa when administered four or five times daily(2009)80 cited
- → Differential Regulation of Rat 5-HT2A and 5-HT2C Receptors after Chronic Treatment with Clozapine, Chlorpromazine and Three Putative Atypical Antipsychotic Drugs(1995)75 cited